What finding should be reported for a client with preeclampsia receiving magnesium sulfate?

In the context of preeclampsia and magnesium sulfate treatment, a urine output of 20 mL/hr is significant and should be reported. This value indicates oliguria, which is a reduction in urine output that can be a warning sign for worsening renal function or imminent complications related to preeclampsia. Magnesium sulfate serves not only as an anticonvulsant but also as a neuroprotective agent; however, it can influence renal function and potentially lead to issues if not monitored effectively. Therefore, any decrease in urine output—especially below 30 mL/hr—should prompt further assessment and potentially require intervention.

When caring for a client with preeclampsia, maintaining a stable blood pressure is essential, as significant fluctuations can indicate complications, but it is not as critical as urine output in this specific context. Healthy urine output is an indication that the kidneys are functioning well, and changes in this can suggest worsening of the mother's or fetus's condition. Stable reflexes also signal normal neurological function and are not indicative of immediate concerns in this scenario. Thus, the 20 mL/hr urine output is a clear finding that requires additional attention.